Promoter Accessibility
Promoter Accessibility is a genomic regulatory feature that denotes the physical availability of a promoter region to transcriptional machinery, distinguished by its dependence on chromatin state, DNA methylation, and nucleosome positioning to modulate gene expression initiation.
62
Publications
4.3K
Citations
418
Authors
152
Institutions
Publications per year
2017–2026
23
Parents
62
1–5 of 62
418
Max Planck Institute of Immunobiology and Epigenetics, Germany
2 publications · 435 citations
2
h-index
2
h-index
2
h-index
2
h-index
Icahn School of Medicine at Mount Sinai, United States
3 publications · 135 citations
2
h-index
1–5 of 418
152
Harvard University
Cambridge, United States
6 h-index
18 publications
3K citations

Howard Hughes Medical Institute
Chevy Chase, United States
5 h-index
16 publications
920 citations

Johns Hopkins University
Baltimore, United States
3 h-index
19 publications
384 citations
University of Massachusetts Chan Medical School
Worcester, United States
3 h-index
13 publications
1.1K citations
Louisiana State University
Baton Rouge, United States
3 h-index
17 publications
649 citations

Icahn School of Medicine at Mount Sinai
New York, United States
3 h-index
29 publications
2.2K citations
Dana-Farber/Harvard Cancer Center
Boston, United States
2 h-index
3 publications
220 citations

Old Dominion University
Norfolk, United States
2 h-index
3 publications
97 citations
1–8 of 152
5 publications · 574 citations
5
h-index
PNAS · 5 publications · 524 citations
5
h-index
4 publications · 140 citations
4
h-index
MCB · 4 publications · 290 citations
4
h-index
3 publications · 92 citations
3
h-index
1–5